Understanding Bank Returns on Derivative Transactions with Corporate Counterparties. July 10, 2014

Similar documents
XVA S, CSA S & OTC CLEARING

Challenges in Refinancing P3 Debt in Canada:

Supplementary Regulatory Capital Disclosure

CVA. What Does it Achieve?

Supplementary Regulatory Capital Disclosure

Supplementary Regulatory Capital Disclosure

Challenges in Managing Counterparty Credit Risk

Hedging CVA. Jon Gregory ICBI Global Derivatives. Paris. 12 th April 2011

Strategies For Managing CVA Exposures

Calculating Counterparty Exposures for CVA

P2.T6. Credit Risk Measurement & Management. Jon Gregory, The xva Challenge: Counterparty Credit Risk, Funding, Collateral, and Capital

The Goldman Sachs Group, Inc. PILLAR 3 DISCLOSURES

PILLAR 3 DISCLOSURES

PILLAR 3 DISCLOSURES

The Role of Counterparty Risk in the Credit Crisis

CVA in Energy Trading

Standardised Risk under Basel 3. Pardha Viswanadha, Product Management Calypso

OIS and Its Impact on Modeling, Calibration and Funding of OTC Derivatives. May 31, 2012 Satyam Kancharla SVP, Client Solutions Group Numerix LLC

INTRODUCTION. This document is not audited and should be read in conjunction with our Q Quarterly Report to Shareholders and 2017 Annual Report.

TECHNICAL ADVICE ON THE TREATMENT OF OWN CREDIT RISK RELATED TO DERIVATIVE LIABILITIES. EBA/Op/2014/ June 2014.

Credit Risk Modelling This course can also be presented in-house for your company or via live on-line webinar

Credit Risk Modelling This in-house course can also be presented face to face in-house for your company or via live in-house webinar

Credit Valuation Adjustment

The Goldman Sachs Group, Inc. PILLAR 3 DISCLOSURES

Q2 15. Supplementary Regulatory Capital Disclosure. For the Quarter Ended - April 30, 2015

In various tables, use of - indicates not meaningful or not applicable.

City of Portland Interest Rate Exchange Agreement Policy

Basis Swap Vaulation Pratical Guide

Counterparty Credit Risk under Basel III

Managing capital and liquidity impacts on collateral management

The Goldman Sachs Group, Inc. PILLAR 3 DISCLOSURES

MORGAN STANLEY SMITH BARNEY LLC CONSOLIDATED STATEMENT OF FINANCIAL CONDITION AS OF JUNE 30, 2017 (UNAUDITED)

Pricing Counterparty Risk in Today s Market: Current Practices

Overview of ISDA Standard Credit Support Annex (SCSA)

Derivatives Use Policy. Updated and Approved by the Board of Trustees November 13, 2014

Interest Rate Risk Management Refresher. April 29, Presented to: Howard Sakin Section I. Basics of Interest Rate Hedging?

Q4 16. Supplementary Regulatory Capital Information. For the Quarter Ended October 31, For further information, contact:

The Basel Committee s December 2009 Proposals on Counterparty Risk

The OIS and FVA relationship. Ion Mihai, PhD Client Solutions Group

Q1 16. Supplementary Regulatory Capital Information. For the Quarter Ended January 31, For further information, contact:

Traded Risk & Regulation

PILLAR 3 DISCLOSURES

Platte River Power Authority Interest Rate Risk Management Policy

Pillar 3 Disclosures (OCBC Group As at 31 December 2016)

CALCULATING CAPITAL REQUIREMENTS FOR SETTLEMENT AND COUNTERPARTY CREDIT RISK

Interest Rate Risk Management Refresher. April 27, Presented to: Section I. Basics of Interest Rate Hedging?

COLLATERAL DISCOUNTING: WHAT DOES DISCOUNTING HAVE TO DO WITH A COLLATERAL AGREEMENT?

Deutsche Bank Global Markets Ex-Ante Cost Disclosure 2018

Capital Optimization Through an Innovative CVA Hedge

Supplementary Regulatory Capital Disclosure and Pillar 3 Report

Counterparty Credit Risk and CVA

Note 10: Derivative Instruments

Pillar 3 Disclosures (OCBC Group As at 31 December 2015)

Introduction to Derivative Instruments Part 2

March 26, Why Hedge? How to Hedge? Trends and Strategies in Interest Rate and FX Risk Management

The Next Steps in the xva Journey. Jon Gregory, Global Derivatives, Barcelona, 11 th May 2017 Copyright Jon Gregory 2017 page 1

CVA Risk Management Working Group Report -Towards the Introduction of Market-based CVA-

Leverage Ratio Disclosure Template A. Summary Comparison (Table 1)

Basel Committee on Banking Supervision. Basel III counterparty credit risk - Frequently asked questions

Basel III Pillar 3 Disclosures Report. For the Quarterly Period Ended December 31, 2015

Assets and liabilities measured at fair value Table 77 As at October 31, 2015

Pillar 3 and regulatory disclosures Credit Suisse Group AG 2Q17

Q2 17. Supplementary Regulatory Capital Information. For the Quarter Ended April 30, For further information, contact:

Q3 18. Supplementary Regulatory Capital Information. For the Quarter Ended July 31, For further information, contact:

Q2 18. Supplementary Regulatory Capital Information. For the Quarter Ended April 30, For further information, contact:

Basel III Pillar 3 Disclosures Report. For the Quarterly Period Ended June 30, 2016

Building a Zero Coupon Yield Curve

IFRS 13 - CVA, DVA AND THE IMPLICATIONS FOR HEDGE ACCOUNTING

Q1 18. Supplementary Regulatory Capital Information. For the Quarter Ended January 31, For further information, contact:

Bank ALM and Liquidity Risk: Derivatives and FVA

FINCAD s Flexible Valuation Adjustment Solution

Counterparty Risk and CVA

Unaudited Consolidated Financial Statements of NAV CANADA. Three and nine months ended May 31, 2010

Financial Statements. For the year ended 30 June 2017

IFRS 13 Fair Value Measurement Incorporating credit risk into fair values

Goldman Sachs Group UK Limited. Pillar 3 Disclosures

Supplemental Regulatory Capital Disclosure

Case 11-2(a) Instrument 1 Collateralized Debt Obligation

Traded Risk & Regulation

GFOA Advisory. Use of Debt-Related Derivatives Products

Pillar 3 Disclosures (OCBC Group As at 31 December 2014)

Break clauses and Derivatives Valuation

BOT Notification No (6 September 2017)-check

Regulatory Landscape and Challenges

Domestic Financial Markets Are Interconnected and Help Each Other to Function Optimally

1.2 Product nature of credit derivatives

The Goldman Sachs Group, Inc. PILLAR 3 DISCLOSURES

Shifting Sands: Creditor Alignment, Cohesion and Committees in Large Value Insolvencies

The Goldman Sachs Group, Inc. PILLAR 3 DISCLOSURES

GFOA Advisory. Use of Debt-Related Derivatives Products

Pillar 3 Regulatory Disclosure (UK) As at 31 December 2012

Q4 18. Supplementary Regulatory Capital Information. For the Quarter Ended October 31, For further information, contact:

MiFID II: Information on Financial instruments

Counterparty Credit Risk

Habib Bank AG Zurich. Annual disclosures according to Basel III (Year 2015)

Risk and treasury management

Funding Value Adjustments and Discount Rates in the Valuation of Derivatives

Supplemental Regulatory Capital Disclosure

Financial Transaction Tax An ICAP discussion document. April 2013

Consultative Document on Incentives to Centrally Clear OTC Derivatives

Transcription:

Understanding Bank Returns on Derivative Transactions with Corporate Counterparties July 10, 2014

Overview Recent regulatory changes, including Basel III, are have far reaching implications for banks pricing of derivatives to end users such as corporations and private equity sponsors. In this environment. Nauset Derivative Advisory concentrates on working with end users to reduce derivative related funding costs on new and existing hedge positions. Nauset has a special emphasis on reducing credit charges brought about by Basel III and CVA, and in executing in illiquid underlyings. Nauset Derivative Advisory 2

Interest Rate Swap Pricing Determinants I. Market Swap rate the price at which a bank would transact with a collateralized counterparty Government bonds Swap spreads Basis Swap II. Swap Credit Spread Adjusts the market price for banks analysis and pricing of counterparty credit risk. Return on Equity Capital Regulator driven Pricing varies widely varies amongst global banks Credit Value Adjustment (CVA) Market price of credit Driven by credit spreads, PD, and LGD The all in swapped rate payable by a Corporate Counterparty is the sum of Market Swap rate and Swap Credit Spread Nauset Derivative Advisory 3

Top Line Revenue $100mm 10 year Interest Rate Swap (PV01= $89,800) I. Market Swap rate the price at which a bank would transact with a collateralized counterparty Bank executes with Corporate at: 2.68% Bank offsets risk in market at: 2.67% Execution revenue (1 bp) $89,800 II. Swap Credit Spread Adjusts the market price for banks pricing of counterparty credit risk. Credit Spread for BB counterparty 0.20% Swap credit spread revenue (20 bp) $1,796,000 Bank revenue derived from Swap Credit Spread is significant. Corporations should have a method of analyzing bank returns when negotiating spread. Nauset Derivative Advisory 4

I. Market Pricing and Execution in Less Liquid Underlyings

Competitive pricing via multiple bids SWAP SPREAD VOLATILITY 30 YEAR SPREAD Execution History/Market Risk to End User Requesting multiple bids in illiquid underlyings moves market against end users. In May 2012 30 swap spreads narrowed and provided an attractive opportunity for fixed rate payers. A corporate counterparty attempted to benefit from low Canadian swap spreads late May. However, asking multiple counterparties for pricing resulted in the market moving from 7 bps to 32 bps (approx notional $500mm) Based on $500mm notional and 25bps execution slippage, incremental hedging cost to the Corporate Counterparty had PV ( Loss ) of $23.775mm ( 25bps x $951,000 PV01) Attempting to achieve best price execution by way of multiple bank bids is self defeating Nauset Derivative Advisory 6

Market Pricing and Execution Considerations 1) Bidding by multiple banks will adversely move the market 2) Banks without capabilities in Canadian curve (or other Illiquid underlyings) have no natural offsets, and will offer inferior pricing 3) Limiting the number of execution providers will eliminate the adverse movements associated with transacting in illiquid sectors of curves. 4) In many cases, savings may be achieved by appointing a sole execution provider 5) Third party verification is required to ensure end price shown to client is consistent with inputs (government bonds, swap spreads) at time of execution. Nauset Derivative Advisory provides Execution Advisory expertise to ensure end users achieve best market pricing. Nauset Derivative Advisory 7

II. Swap Credit Spread Equity Capital Credit Value Adjustment (CVA)

Swap Credit Spread Equity Capital COUNTERPARTY CREDIT RISK (CCR) CHARGE Derivatives exposures are calculated over the contract s life to determine a loan equivalent value for purposes of applying equity capital. The CCR risk charge (aka Default Risk Capital charge) takes into account MTM movements in the underlying derivative and adjusts for credit risk of the corporate counterparty. CREDIT VALUE ADJUSTMENT (CVA) RISK CAPITAL CHARGE Basel III introduced a CVA Risk Capital Charge to cover the risk of MTM losses on expected counterparty risks (ie. CVA adjustments) This in addition to the already existing Default Risk Capital requirement for CCR (the CCR charge) determined on models prescribed in Basel I through III, is significantly increasing the derivative credit spread charged to end users Conflicting adoption of Equity Capital models by global banks is resulting in divergent credit spread pricing to End Users. ( regulatory arbitrage ) Nauset Derivative Advisory 9

Swap Credit Spread Credit Value Adjustment Credit Value Adjustment ( CVA ) is the market price of taking counterparty risk over the life of a OTC derivative transaction Used by banks as a cost of taking counterparty credit risk over the life of a derivative contract. Complex for banks to price and hedge, resulting in pricing disparity among global banks. >Recovery rates >Default Probabilities >Cross asset nature of books / Netting >EPE/ENE >Hedge Treatment >Termination Events Cost to banks of facing a counterparty over the life of a derivative heavily assumption driven Nauset Derivative Advisory 10

Swap Credit Spread CVA and Profitability Bank A Bank B Counterparty Credit Spread (10 year) 300 bps 300 bps Bank Credit Spread (10 year) 109 bps 169 bps Exposure Assumption Base Case 10% lower (EE) Bilateral CVA $1,418,000 (16 bps) $ 685,000 (7.75 bps) Swap Credit Spread quote $4,254,933 (48.5 bps) $3,767,500 (42.5 bps) Less: Bilateral CVA cost $1,418,000 (16 bps) $ 685,000 (7.75 bps) Profitability to Banks $2,836,622 $3,053,600 Despite providing End User with a lower swap credit spread, Bank B s profitability is significantly higher. Bank s profitability is reduced by CVA charges. Simply choosing the bank with lowest credit spread does not mean a Corporate Counterparty could not have dealt at a better price. Nauset Derivative Advisory 11

III. Ancillary Revenue and Bank Share of Wallet

Ancillary Bank Revenue Components Bank loans: Capital utilization based on committed and drawn amounts Revenue and ROE relatively easy to model due to known committed facilities Equity origination / M&A / Debt Capital Market origination Theoretically viewed as revenue that does not attract equity capital utilization ROE is infinite OTC Derivatives: Loan Equivalent exposures must be calculated to which capital percentages can be applied. Opaque nature of models makes it very difficult for a corporate counterparty to calculate expected exposures ( loan equivalent ) when estimating Bank s profitability and return on equity. Corporations and Financial Sponsors can gain negotiating leverage in Bank pricing with an understanding of Derivative profitability Nauset Derivative Advisory 13

Ancillary Bank Revenue Loan Equivalent Exposure $100mm USD interest rate swap does not translate to $100mm of Loan Equivalent Exposure. ROE should be based on capital employed on Expected Exposures. Nauset helps corporations and financial sponsors calculate derivative profitability paid to Bank Group in context of overall ancillary revenue. Nauset Derivative Advisory 14

IV. Sole Execution Mandates

Sole Execution Mandate Relative Revenue Banks market their ability to execute transactions in relatively illiquid underlyings, and secure lucrative Sole Execution mandates. The bank then executes the entire transaction and syndicates the market hedge to other syndicate members. Syndicate banks apply swap credit spread to achieve target ROE PV01 total New Swap $ 89,800 PV01 of Syndicate Bank Hold Amounts (20%) $ 17,960 Syndicate Bank Hold revenue (15 bps) Top Line: $269,400 Post CVA $140,000 Execution Bank revenue (4 bps on total) $359,200 Execution Bank ROE is virtually infinite due to CSAs with bank syndicate counterparties Sole Execution Bank has opportunity to generate significantly higher revenue than Hold Banks, without incurring additional capital utilization Nauset Derivative Advisory 16

V. Early Termination Clauses and Opportunities for Banks to Generate Incremental Revenue

Early Termination Clauses» Early Termination Clauses (ETC s) are used by banks as a Credit Mitigant for long dated derivative exposures with corporate counterparties.» Typically are included in confirmations when tenor of derivative is greater than the term for which bank would otherwise lend to the counterparty» Enables bank to exit (terminate) transaction at a specified date prior to maturity Early Termination Clause provides a safety valve for bank if credit worthiness of corporate counterparty deteriorates Nauset Derivative Advisory 18

Early Termination Clauses Post Financial Crisis» The 2008 financial crisis had (among other things) the following effects on the OTC derivative markets Dramatic decline in yields, resulting in large MTM s on positions in which banks were receiving fixed rates An increase in capital that must be employed against OTC derivative positions (Basel III) Post financial crisis, Global Banks returns on Legacy positions deteriorated dramatically Nauset Derivative Advisory 19

Early Termination Clauses Incremental Revenue $100mm 15 year interest rate swap maturing July 10, 2023 Execution Date: July 10, 2008 Fixed rate: 5.00% Early Termination Clause Exercise Date August 1, 2014 MTM July 10, 2014 (9 year IRS = 2.50%) $20,850,000 The MTM owing to the bank translates to a Risk Weighted Asset for which capital must be set aside. Nauset Derivative Advisory 20

Early Termination Clauses» Bank has right to terminate the transaction and receive a $20,850,000 termination payment» May create a liquidity problem for corporate counterparty» In lieu of termination payment, Bank may instead attempt to negotiate a higher fixed rate on swap for remaining term to generate acceptable ROE on legacy position» Bank suggests increasing fixed rate from 5.00% to 5.20% for remaining term PV of incremental interest expense: $1,667,000 (20 x $83,350) Return on Equity to Bank of Incremental Revenue??? Nauset works with corporations and financial sponsors to ensure derivative related restructurings costs are minimized and are commercially reasonable. Nauset Derivative Advisory 21

Nauset Derivative Advisory EXECUTION ADVISORY CREDIT MITIGANT RESTRUCTURING ANALYSIS DERIVATIVE PORTFOLIO COUNTERPARTY OPTIMIZATION» Ensure market transparency of bank execution,» Swap credit spread analysis (CVA/FVA) and fairness opinions» Analysis of marks-to-market on legacy positions» Negotiation of optimal credit mitigation terms on new transactions» Portfolio Modifications» Vettting of commercial terms of ISDA and confirmations» Expertise in illiquid underlyings» Analysis of CVA/Equity Capital charges for extension of derivative contracts beyond initial mitigation date» Adjudication of pricing concessions offered by banks for changed mitigation terms» Verification and negotiation of cash settlement amounts offered on terminations/unwinds» Calculation and negotiation of potential FVA and/or funding charges on transaction novations» Analysis of CVA/FVA and Equity Capital charges held by banks against legacy positions» Novation Exercises across asset classes» Netting benefit discovery» Debt/Derivative refinancing» Collateralization replacement Nauset Derivative Advisory 22